---
title: "Prices of 137 Cancer Medicines to Fall from November 9; Reductions of Up to 70% Expected"
english_title: "137 Cancer Medicines to Get Price Cuts from November 9"
publisher: "Truevision English News"
canonical_url: "https://english.truevisionnews.com/news/387784/cancer-medicine-price-cuts-november-9"
published_at: "2026-10-19T17:51:00+05:30"
category: "Big Story"
language: "en"
image: "https://cf.zdn.im/img/truevisionnews.com/0/image-uploads/6ad60be17059a_cancer-medicine-price-cuts-november-9.jpg"
keywords: ["CancerMedicinePriceCuts", "CancerTreatmentCosts", "TradeMarginRationalisation", "NPPA", "PharmaSahiDaam"]
---

# Prices of 137 Cancer Medicines to Fall from November 9; Reductions of Up to 70% Expected

> **Lead Summary:** New Delhi: Prices of 137 cancer medicines will be reduced from November 9 under the Trade Margin Rationalisation of selected medicines by up to 70%.

## Article Content

New Delhi: Prices of 137 cancer medicines will be reduced from November 9 under the Trade Margin Rationalisation of selected medicines by up to 70%.

The extent of the reduction will vary depending on each medicine’s existing pricing structure. Trade margins charged within the distribution and sales network will also be capped at 30% of the medicines’ MRP.

The price-control measures will cover several categories of cancer medicines, including immunotherapy drugs. Key medicines used in the treatment of breast, prostate, colorectal, ovarian and cervical cancers are included.

The medicines covered include immunotherapy drugs used to treat more than 20 types of cancer. Pembrolizumab, durvalumab and osimertinib are among the widely used cancer medicines listed under the measures.

Denosumab, used for patients with breast and prostate cancers, is also included. Pegfilgrastim, administered to prevent neutropenia in cancer patients, will come within the price-control framework.Bevacizumab, used in the treatment of colorectal, ovarian and cervical cancers, is another medicine covered by the reductions.

The primary objective is to curb excessive profits within the wholesale and retail medicine supply chains. The government has said the measures will also ensure fair returns for manufacturers and prevent artificial shortages in the market.

Members of the public can check the revised medicine prices through the Pharma Sahi Daam mobile application or the official website of the National Pharmaceutical Pricing Authority (NPPA).

### Related Links & Sources
- [Original Story Source](https://english.truevisionnews.com/news/387784/cancer-medicine-price-cuts-november-9)